Katie is a member of the Life Sciences Health Industry Group in the Washington, D.C. office. She represents a variety of health care providers, suppliers, manufacturers, and associations regarding regulatory issues arising under the Medicare and Medicaid programs and under the health care fraud and abuse laws, including anti-kickback, physician self-referral, beneficiary inducement, and false claims laws. She also assists clients involved in anti-kickback, Stark Law, and False Claims Act investigations and litigation matters. Additionally, she works with clients to develop, implement, and monitor health care fraud and abuse and corporate compliance programs. Katie also regularly counsels pharmaceutical and medical device manufacturers regarding federal and state marketing restrictions and reporting requirements, including the “Sunshine” provisions of the Affordable Care Act, known as the Physician Payment Sunshine Act.
- 26 January 2017 "Drug, Device Company Payments to Doctors Top $7 Billion" Bloomberg BNA's Health Care Fraud Report